The development of Metal Injection Molding of Titanium technology applied at Element 22 reaches as far back as the late 1980’s, when the renowned Fraunhofer IFAM Institute in Bremen, Germany cooperated with the HZG Helmholtz Institute in Geesthacht, Germany to research using Titanium powder in production processes. Element 22 is the commercial entity born from the decades of this research and continues to maintain close relationships with these highly respected institutions to this day.
The first commercial lines for Titanium MIM components were installed in 2004 by the Element 22’s predecessor. The focus was uniquely on the development and production of medical components creating a strong knowledge base for that market. In September 2011, Element 22 acquired the assets of that company with a superior strategy and vision for successfully growing the business. Six years later, Element 22 has the largest Ti MIM manufacturing capacity in the world.